Last reviewed · How we verify
NCT03505086: BITE
Bleeding In Thrombocytopenia Explained
trial testing Blood withdrawal in Hematologic Neoplasms in 1,000 participants. Currently enrolling.
1 October 2022
Quick facts
| Lead sponsor | Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 4 December 2018 |
| Primary completion | 1 October 2022 |
| Estimated completion | 1 June 2026 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Blood withdrawal — full drug profile →
- Questionnaire for former bleeding events
Conditions studied
- Hematologic Neoplasms — all drugs for Hematologic Neoplasms →
- Bleeding — all drugs for Bleeding →
- Hemorrhage — all drugs for Hemorrhage →
- Platelet Transfusion — all drugs for Platelet Transfusion →
Sponsor
Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research
Who can join
18 and older, any sex, with Hematologic Neoplasms or Bleeding. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Multicenter case cohort study investigating clinical risk factors for clinically relevant bleeding in hemato-oncology patients, as well as bleeding related biomarkers during intensive treatment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Risk factors for bleeding in haemato-oncology patients-a nested case-control study: The BITE study protocol (Bleeding In Thrombocytopenia Explained).
Cornelissen LL, Caram-Deelder C, van der Bom JG, Middelburg RA, et al · · 2020 · cited 2× · PMID 32606056 · DOI 10.1136/bmjopen-2019-034710
Verify or expand the search:
- PubMed search for NCT03505086
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood withdrawal
Trials testing the same drug.
- NCT06113705 — Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study. · NA · recruiting
- NCT06847100 — Artificial Intelligence Models to Predict Clinically Relevant Cardiovascular Outcomes · completed
- NCT05539183 — Collection of Pleural Effusion Fluid · NA · unknown
- NCT05510596 — Magnetic Resonance Imaging in Immune Effector Cell-Associated Neurotoxicity Syndrome · NA · completed
- NCT05754645 — The Microbiome in (Non-) Obese Pregnancy and Pregnancy Outcomes · recruiting
Other recruiting trials for Hematologic Neoplasms
Currently open trials in the same condition.
- NCT07519811 — LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL) · NA · recruiting
- NCT07485855 — Influenza Vaccination Strategy for Patients With Hematologic Malignancy · Phase 3 · recruiting
- NCT07162038 — Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA- · Phase 1 · recruiting
- NCT06685848 — Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion · NA · recruiting
- NCT06433349 — A Multi-center Investigation of Family Health. · recruiting
Other Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research trials
Trials by the same sponsor.
- NCT04626661 — Mitochondrial Oxygen Measurement Variability in Critically Ill Patients (INOX Variability Study) · completed
- NCT06176105 — Mortality After Transfusion of Ever-pregnant Donor Red Blood Cells · completed
- NCT03842722 — Insufficient Oxygenation in Septic Patients · completed
- NCT03092297 — Insufficient Cellular Oxygen in ICU Patients With Anaemia · terminated
- NCT03110887 — Monitoring Outcome in Neonatal Thrombocytopenia · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03505086 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research
- Last refreshed: 21 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03505086.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing